Daily Hot Takes from SOCU 2026: Day 1 Highlights
Day 1 of the 17th Annual Skin of Color Update (SOCU 2026) opened with a historic sense of community, reflection, and relentless dedication to advancing dermatologic care for patients with skin of color.
Co-Chairs Andrew F. Alexis, MD, MPH, FAAD, and Eliot F. Battle, MD, welcomed attendees from across the globe—spanning Europe, the Caribbean, the UK, and across the United States—marking 17 y …
Day 1 of the 17th Annual Skin of Color Update (SOCU 2026) opened with a historic sense of community, reflection, and relentless dedication to advancing dermatologic care for patients with skin of color.
Co-Chairs Andrew F. Alexis, MD, MPH, FAAD, and Eliot F. Battle, MD, welcomed attendees from across the globe—spanning Europe, the Caribbean, the UK, and across the United States—marking 17 y … Continue reading "Daily Hot Takes from SOCU 2026: Day 1 Highlights"
Parade asked the question consumers often ponder in the skincare aisle: Does expensive skin care work better? Dermatologists quoted in the article say no – formula matters more than price. They say a higher price can reflect high-quality ingredients, scientific research, and a more cosmetically elegant scent or texture. However, the increased costs can also reflect marketing expenditures, includ … 
Photodynamic therapy (PDT) involves a lot of choices for a clinician, from deciding how to prepare the skin for a photosensitizer to selecting the light source. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, addresses proven strategies for PDT in this interview with ODAC Conference Co-Chair Vishal A. Patel, MD, FACMS. Watch as Dr. Patel outlines varied options for enhanci … 
Delgocitinib is a topical pan-Janus kinase (JAK) inhibitor that represents a novel non-steroidal treatment mechanism for chronic hand dermatitis. As a pan-JAK inhibitor, delgocitinib blocks all four members of the JAK family (JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2)), thus simultaneously modulating the many cytokine pathways that drive chronic inflammatory skin disorders. Delgocitinib was in … 
New treatments are giving alopecia patients hope, according to ODAC Medical Dermatology Advisor Jennifer Soung, MD, FAAD. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Soung, who shares her pearls for the medical treatment of alopecia. Watch as Dr. Soung outlines the AST tool to determine alopecia severity. Hear a summary of approved JAK inhibitors for al …